 - Patients who are carriers of BRCA 12 mutations or at high risk for hereditary breast cancer due to strong family history more than one pre-menopausal family member with breast cancer or any ovarian cancer are excluded because of the increased potential for in-breast recurrence elsewhere in the breast in the absence of whole breast radiotherapy. 